Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

117.70 -1.05 (-0.88%)
Streaming Delayed Price Updated: 11:31 AM EDT, Jul 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,487,268
Open 117.05
Bid (Size) 117.64 (2)
Ask (Size) 117.75 (2)
Prev. Close 118.75
Today's Range 116.93 - 123.74
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
10 worst performing large-cap stocks last week: Walgreens, Floor & Decor, Moderna, Birkenstock, BeiGene, Pool Corp, JD.com, Ecopetrol, International Paper, Micron. 
Via Benzinga
What's Going On With Moderna Stock Friday?
Moderna's RSV vaccine, mRNA-1345, is designed to protect adults aged 60 and older from respiratory disease caused by the RSV infection. 
Via Benzinga

Performance

YTD
+4.62%
+4.62%
1 Month
-17.43%
-17.43%
3 Month
+11.46%
+11.46%
6 Month
+4.62%
+4.62%
1 Year
-3.31%
-3.31%

More News

Read More
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
Via ACCESSWIRE
In-Depth Examination Of 10 Analyst Recommendations For Moderna
Via Benzinga
Moderna's Options: A Look at What the Big Money is Thinking
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today
Via Benzinga
Market Whales and Their Recent Bets on MRNA Options
Via Benzinga
Silver Prices Fell To A 6-Week Low
Via Talk Markets
Topics Bonds Economy
Exposures Debt Markets Interest Rates
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
Via Benzinga
2 Stocks Down More Than 30% to Buy Right Now
Via The Motley Fool
Exposures COVID-19
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dow Nearly 100 Points Lower Amid Slumping Home Sales
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Is Moderna Stock Trading Lower On Wednesday?
Via Benzinga
Exposures COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
Via Investor's Business Daily
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
S&P 500, Nasdaq Lurking Below Record Highs
Via Talk Markets
Topics Stocks
Exposures US Equities
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Via Benzinga
Exposures COVID-19
The RBA Kept Interest Rates On Hold And Remained Hawkish
Via Talk Markets
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
Via MarketBeat
Exposures COVID-19
Moderna Just Gave Investors Another Reason to Buy the Stock
Via The Motley Fool
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.